A sensitive and versatile bioluminescence bioassay for HIV type 1 based on adenoviral vectors

AIDS Research and Human Retroviruses

Volumn 15, Issue 8, 1999, Pages 759-767

  Axelrod, Jonathan H ^a,b   Honigman, Alik ^a  

^a HEBREW UNIVERSITY   (Israel)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS VECTOR;

ADENOVIRUS; ARTICLE; BIOLUMINESCENCE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; PRIORITY JOURNAL; VIRUS DETECTION;

ADENOVIRIDAE; ANTI-HIV AGENTS; BIOLOGICAL ASSAY; CELL LINE; GENE PRODUCTS, TAT; GENES, REPORTER; GENETIC VECTORS; HELA CELLS; HIV INFECTIONS; HIV LONG TERMINAL REPEAT; HIV-1; HUMANS; LUCIFERASES; LUMINESCENT MEASUREMENTS; ZIDOVUDINE;

EID: 0033586983     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/088922299310845     Document Type: Article

References (21)

1. Felber BK and Pavlakis GN: A quantitative bioassay for HIV-1 based on trans-activation. Science 1988;239:184-187.
2. Hsu M-C, Schutt AD, Holly M, Slice LW, Sherman MI, Richman DD, Potash MJ, and Volsky DJ: Inhibition of HIV replication in acute and chronic infections in vitro by a Tat antagonist. Science 1991;254:1799-1802.
3. Israel S and Honigman A: A bioluminescence assay for gene expression by continuously growing mammalian cells: Application for detection of human immunodeficiency virus type 1 (HIV-1).Gene 1991;104:139-145.
4. Kimpton J and Emerman M: Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated beta-galactosidase gene. J Virol 1992;66:2232-2239.
5. Aguilar-Codova E, Chinen J, Donehower L, Lewis DE, and Belmont JW: A sensitive reporter cell line for HIV-1 tat activity, HIV-1 inhibitors, and T cell activation effects. AIDS Res Hum Retroviruses 1994;10:295-301.
6. Dorsky DI, Wells M, and Harrington RD: Detection of HIV-1 infection with a green fluorescent protein reporter system. J Acquir Immune Defic Syndr Hum Retrovirol 1996;13:308-313.
7. Frankel AD and Pabo CO: Cellular uptake of the Tat protein from human immunodeficiency virus. Cell 1988;55:1189-1193.
8. Hit M, Bett AJ, Prevec L, and Graham FL: Construction and propagation of human adenovirus vectors. In: Cell Biology: A Laboratory Handbook (Cells J, ed.). Academic Press, San Diego, California, 1994, pp. 479-490.
9. Trapnell BC and Gorziglia M: Gene therapy using adenoviral vectors. Curr Opin Biotech 1994;5:617-625.
10. Bramson JL, Graham FL, and Gauldie J: The use of adenoviral vectors for gene therapy and gene transfer in vivo. Curr Opinion Biotech 1995;6:590-595.
11. Rosen CA, Sodroski JG, and Haseltine WA: The location of cis-acting regulatory sequences in the human T cell lymphotropic virus type III (HTLV-III/LAV) long terminal repeat. Cell 1985; 41:813-823.
12. Rosen CA: HIV regulatory proteins: Potential targets for therapeutic intervention. AIDS Res Hum Retroviruses 1992;2:175-181.
13. Graham FL, Smiley J, Russel WC, and Nairn R: Characterization of human cell line transformed by DNA from human adenovirus type 5. J Gen Virol 1977;36:59-72.
14. Gazdar AF, Carney DN, Bunn PA, Russell EK, Jaffe ES, Schechter GP, and Guccion JG: Mitogen requirements for the in vitro propagation of cutaneous T-cell lymphomas. Blood 1980;55:409-417.
15. Steinitz M, Tamir S, and Goldfarb A: Human anti-pneumococci antibody produced by an Epstein-Barr virus (EBV) immortalized cell line. J Immunol 1984;132:877-882.
16. deWet JR, Wood KV, DeLuca M, Helinski DR, and Subramani S: Firefly luciferase gene: Structure and expression in mammalian cells. Mol Cell Biol 1987;7:725-737.
17. McGrory WJ, Bautista DS, and Graham FL: A simple technique for the rescue of early region I mutations into infectious human adenovirus type 5. Virology 1988;163:614-617.
18. Graham FL and Van der Eb AJ: A new technique for the assay infectivity of human adenovirus 5 DNA. Virology 1973;52:456-467.
19. Nabel GJ, Rice SA, Knipe DM, and Baltimore D: Alternative mechanisms for activation of human immunodeficiency virus in T cells. Science 1988;239:1299-1302.
20. Jones KA: HIV trans-activation and transcription control mechanisms. New Biol 1989;1:127-135.
21. Biswas DK, Salas TR, Wang F, Ahlers CM, Dezube BJ, and Pardee AB: A tat-induced auto-up-regulatory loop for superactivation of the human immunodeficiency virus type 1 promoter. J Virol 1995;69:7437-7444.